Management of acute spinal cord compression in multiple myeloma
revlimid multiple myeloma :: Article Creator Cranial Nerve Palsy May Be Present After Cilta-Cel For Multiple Myeloma ConferencesONS Annual Congress A subgroup of patients from the 3 CARTITUDE trials experienced cranial nerve palsy after treatment, most of whom were men. Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma At a median of 3 weeks post-infusion, there was a subgroup of patients with multiple myeloma who were treated with ciltacabtagene autoleucel (cilta-cel; Carvykti) in the 3 different CARTITUDE trials experienced cranial nerve palsy (CNP), according to findings from a poster presentation from the 2024 Oncology Nursing Society Conference.1 Cases of CNP were experienced mostly in male patients and were low-grade, with most cases resolving after a short time on corticosteroid treatment. Additionally, those with cytokine release syndrome or immune effector-associated neurotoxicity syndrome (IC...